Plain-English translation of NCT05072691 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is looking at a specific protein marker found in cerebrospinal fluid (the fluid surrounding your brain and spinal cord) to see if it can predict how multiple sclerosis will progress in your body. Researchers believe this marker may help doctors understand whether you're at risk for serious disability or a milder disease course. The study compares this marker in people with MS, people with other nerve conditions, and people without inflammatory nerve diseases.
Currently, doctors have limited tools to predict which MS patients will develop severe disability and which will have a milder course—about 30% of patients stay relatively stable, while 20-30% become severely disabled quickly. This study exists because finding a reliable predictor could help doctors counsel patients better and choose the most effective treatment right from the start.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will have cerebrospinal fluid collected during a routine lumbar puncture (spinal tap) and a brain MRI scan as part of your standard diagnostic workup for neurological disease. Researchers will analyze your spinal fluid to measure the protein marker and compare it with imaging results and clinical information. The study involves about 100 participants total across different diagnostic groups.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
Belgium